Gateway Investment Advisers LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 4.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,715 shares of the company’s stock after selling 2,029 shares during the period. Gateway Investment Advisers LLC’s holdings in Henry Schein were worth $2,776,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the company. CSat Investment Advisory L.P. raised its stake in Henry Schein by 115.6% during the first quarter. CSat Investment Advisory L.P. now owns 552 shares of the company’s stock worth $33,000 after purchasing an additional 296 shares during the period. Parallel Advisors LLC lifted its holdings in shares of Henry Schein by 67.4% during the first quarter. Parallel Advisors LLC now owns 586 shares of the company’s stock worth $35,000 after buying an additional 236 shares during the last quarter. First Hawaiian Bank lifted its holdings in shares of Henry Schein by 66.7% during the first quarter. First Hawaiian Bank now owns 650 shares of the company’s stock worth $39,000 after buying an additional 260 shares during the last quarter. Rational Advisors LLC lifted its holdings in shares of Henry Schein by 1,012.3% during the first quarter. Rational Advisors LLC now owns 723 shares of the company’s stock worth $43,000 after buying an additional 658 shares during the last quarter. Finally, Hudock Capital Group LLC acquired a new position in shares of Henry Schein during the first quarter worth approximately $66,000.
A number of brokerages have recently commented on HSIC. Leerink Swann lowered Henry Schein from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $75.00 to $70.00 in a report on Wednesday, May 15th. They noted that the move was a valuation call. Zacks Investment Research lowered CGI from a “buy” rating to a “hold” rating in a report on Wednesday, June 19th. BidaskClub upgraded Xilinx from a “hold” rating to a “buy” rating in a report on Wednesday, July 24th. Cleveland Research reiterated a “hold” rating on shares of Henry Schein in a report on Thursday, May 2nd. Finally, Craig Hallum lowered Zayo Group from a “buy” rating to a “hold” rating in a report on Wednesday, May 8th. Seven analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $74.13.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.04. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.36 billion. Henry Schein had a net margin of 4.10% and a return on equity of 18.35%. The business’s revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.95 EPS. On average, sell-side analysts expect that Henry Schein, Inc. will post 3.46 EPS for the current fiscal year.
In related news, Director Paul Brons sold 1,758 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $70.96, for a total value of $124,747.68. Following the completion of the transaction, the director now owns 17,582 shares of the company’s stock, valued at approximately $1,247,618.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven Paladino sold 20,712 shares of the company’s stock in a transaction on Wednesday, June 19th. The stock was sold at an average price of $72.17, for a total transaction of $1,494,785.04. Following the completion of the transaction, the chief financial officer now directly owns 166,233 shares of the company’s stock, valued at approximately $11,997,035.61. The disclosure for this sale can be found here. Insiders sold a total of 49,668 shares of company stock valued at $3,572,423 over the last 90 days. 1.06% of the stock is currently owned by company insiders.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Story: What are economic reports?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.